Announcements Trials
Browse Landscape

Phase

Phase 4 7Phase 2 5Phase 1/2 4Phase 3 3Phase NA 2Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 5

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 2Gastrointestinal 2

Conditions

Leukemia, Myeloid, Acute 2Hepatitis C 2Carcinoma, Hepatocellular 2Respiratory Tract Infections 1Respiratory Syncytial Virus Infections 1Recurrence 1Pneumonia 1Neoplasms 1Leukemia 1Hepatitis 1Bronchiolitis Obliterans Syndrome 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Ribavirin × Clear all
NCT02940496 2025-07-15

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

M.D. Anderson Cancer Center

Phase 2 Completed
15 enrolled 8 charts
Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT02073838 2023-09-29

Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML

Jewish General Hospital

Phase 2 Completed
23 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00559091 2022-12-22

Borden-001

Jewish General Hospital

Phase 2 Completed
18 enrolled
Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT01502072 2021-02-15

Respiratory Syncytial Virus - RSV Protocol

M.D. Anderson Cancer Center

Phase 2 Completed
48 enrolled 11 charts

Neoplasms, Pneumonia, Respiratory Tract Infections, Respiratory Syncytial Virus Infections

NCT01559844 2016-07-27

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Gilead Sciences

Phase 2 Completed
61 enrolled 25 charts
Gastrointestinal

Bronchiolitis Obliterans Syndrome, Hepatitis, Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡